Annals of the ATS

Official Twitter account for Annals of the American Thoracic Society; follows, retweets, likes do not indicate endorsement. #MedEd #CriticalCare #AnnalsATS #ATS

[Annals of the ATS @AnnalsATS]

The latest issue of AnnalsATS is live! Take a look:

https://t.co/sCxujADqGw

@atscommunity

[Annals of the ATS @AnnalsATS]

🎧Revisit one of the most popular episodes of Clinician to Clinician

Summary for Clinicians: Clinical Practice Guideline for the Diagnosis and Management of Community-acquired Pneumonia

https://t.co/tXcvAZgMlx

@atscommunity

[Annals of the ATS @AnnalsATS]

Streamlined Peer Review for ATS Journals
Effective June 1, 2026, authors submitting manuscripts to ATS Journals are only required to list conflicts of interest in a paragraph on the title page of the manuscript. Individual disclosure forms are no longer required.

@atscommunity

[Annals of the ATS @AnnalsATS]

Journal Sessions at ATS 2026

NSC27 Discussion and Dialogue with the ATS Journal Editors: How to Get Your Paper Published in ATS Journals

Monday, May 18 from 11:00 AM – 12:00 PM
The Learning Studio in the Networking Super Center
Level 2, OCCC West

[Annals of the ATS @AnnalsATS]

Welcome to ATS 2026!

All attendees will receive free online access to the ATS Journals through June 2, 2026. Stop by the ATS Conference Center in the Networking Supercenter in Hall C to scan the QR code.

[Annals of the ATS @AnnalsATS]

The latest issue of #AnnalsATS is live! Take a look:https://t.co/5S89AqcvCX

@atscommunity

[Annals of the ATS @AnnalsATS]

🎧Revisit this podcast!  Dr. Gregory Tino chats with Dr. Mohamed Zghouzi and Dr. Vikas Aggarwal on their article.
@atscommunity
https://t.co/JZPbXstprE

[Annals of the ATS @AnnalsATS]

The latest issue of #AnnalsATS is now live!
Take a look: https://t.co/Buno5xI7jt

@atscommunity

[American Thoracic Society (ATS) @atscommunity]

When the EPA recently set the statistical value of a human life to nearly $0, it had big ramifications on policy and decision-making. As Anthony Gerber, MD, @universityofky, explains on the ATS Breathe Easy podcast, this new lowered value reduces the economic incentive to better public health and save lives.

Watch the full episode now or tune in wherever you listen to podcasts: https://t.co/wbXKfoG2tm

[Annals of the ATS @AnnalsATS]

Federation, not centralization: a new paradigm for electronic health record–based critical care research
@atscommunity

🔗 https://t.co/z7A64EfkxC

[Annals of the ATS @AnnalsATS]

Visit the New AnnalsATS Site
https://t.co/uoVhJi5mOB

How to sign in using your ATS membership
1. Click on the Profile icon in the top right
2. Click on “Sign in through society site”
3. Enter your ATS membership credentials

[Annals of the ATS @AnnalsATS]

The latest issue of #AnnalsATS is now live!

Take a look: https://t.co/hebuaUGlCS
@atscommunity

[Annals of the ATS @AnnalsATS]

Adverse drug reactions during nontuberculous mycobacterial pulmonary disease treatment: a systematic review and meta-analysis
@atscommunity

🔗 https://t.co/7omNsZBlT5

[Annals of the ATS @AnnalsATS]

Obesity Paradox and Lung Cancer Mortality: The Contributing Roles of Airflow Limitation and Pre–Chronic Obstructive Pulmonary Disease
@atscommunity

🔗 https://t.co/Z7x0MJ7lCU

[Annals of the ATS @AnnalsATS]

New Annals Animated Video!

In adults with undiagnosed respiratory symptoms, more severe cough symptoms were linked to worse lung function and poor quality of life. Read the article at: https://t.co/OoiooZyBl7

https://t.co/5ycVFlXDV7

[Annals of the ATS @AnnalsATS]

Endobronchial ultrasound-guided sampling: diagnostic yield of needle biopsy and cryobiopsy in addition to needle aspiration
@atscommunity

🔗 https://t.co/BuErf97TBy

[Annals of the ATS @AnnalsATS]

Morning Larks and Night Owls: Considering Chronotype in Evaluation of Patients with Pulmonary Hypertension
@ajbryantlab
@atscommunity

🔗 https://t.co/bR8VgCJEAZ

[Annals of the ATS @AnnalsATS]

Inotrope selection in mixed cardiogenic shock w/sepsis

Nationwide cohort w/ cardiogenic shock, sepsis on inotropes, no difference in mortality between milrinone vs. dobutamine-secondary outcomes (LOS, arrhythmia, antiarrhythmic use) favored dobutamine

https://t.co/3AoX2mBuVN

[American Thoracic Society (ATS) @atscommunity]

March 24 is World Tuberculosis Day. As TB expert Philip Hopewell, MD, explained on the ATS Breathe Easy podcast, advancements in TB treatment make it faster and easier to cure this disease. We have the tools, skills and knowledge to find and cure everyone with TB. The ATS urges everyone to organize within our communities to affect the change that matters most. #worldtbday

Watch the full episode now and learn more about global efforts to eradicate TB: https://t.co/khB83W2y53

[Annals of the ATS @AnnalsATS]

Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor

ETI is associated with sustained reductions in airway and circulating markers of inflammation through 2.5 years of therapy

🔗 https://t.co/HN99aEkrUP